Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × TIC10 compound × Clear all

NCT04055649 2025-06-18

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms